-
Mashup Score: 5
Christina Lee, PharmD, and Julia Donahue, PharmD, analyzed 533 encounters revealing a 27.1% readmission rate in immunocompromised patients versus 14.1% in non-immunocompromised patients.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 1
Hydronidone demonstrated significant efficacy in liver fibrosis regression in CHB patients, meeting the primary endpoint in a phase 3 trial. The company plans to file regulatory applications in China and the US, aiming to expand the therapy’s indications.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
Originally published on our sister site, @HCPLiveNews, Gyre Therapeutics’ Hydronidone met the primary endpoint in a Phase 3 trial for CHB-associated liver fibrosis. More info & expert insights from Dr. Lungen Lu: https://t.co/JSJE6dbl4U
-
-
Mashup Score: 2
Long-acting lipoglycopeptides were as effective as daily standard-of-care antibiotics in step-down regimens for serious infections.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
Long-acting lipoglycopeptides were as effective as daily standard-of-care antibiotics in step-down regimens for serious infections. An investigator offers insights on this study. #IDtwitter #Medtwitter https://t.co/rf56SuKuFT
-
-
Mashup Score: 0
At MAD-ID, Dianne Nguyen, MD, shares Phase 3 data showing consistent tolerability of the microbiome therapy across high-risk patient populations
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
🎥 At #MADID2025, Dr. Dianne Nguyen, Head of Medical Affairs for the Pharmaceutical Division at Nestlé Health Science, presented Phase 3 data showing VOWST is well-tolerated in adults with recurrent C diff infection. @MAD_ID_ASP Listen here: https://t.co/wcv5Wl9kSK
-
-
Mashup Score: 4
In a new study presented at MAD-ID, omadacycline was found to have an 86% clinical success rate across a wide-range of infections and pathogens in an immunocompromised population.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
In a new study presented at #MADID2025, omadacycline was found to have an 86% clinical success rate across a wide-range of infections and pathogens in an immunocompromised population. #IDtwitter #Medtwitter https://t.co/JI2FO6FVmQ
-
-
Mashup Score: 8MAD-ID - 5 day(s) ago
Contagion® is a news resource for infectious disease specialists and practitioners, aiding identification, diagnosis, treatment and prevention.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
We’ve touched down in Orlando for #MADID2025! 🌴 We’re looking forward to our 15+ on-site interviews w/ leading clinicians & sharing their important work in ID & AMR with our audience. @MAD_ID_ASP You can find our coverage here: https://t.co/GUVFIpDpK9 https://t.co/AfyUbbuR3Z
-
-
Mashup Score: 1
This activity has been approved for AMA PRA Category 1 Credits ™. REGISTRATION DEADLINE: SEPTEMBER 2, 2025 | 5:00 PM Registering for this course includes 2 full days of in-person learning and access to our online course, Advanced Topics in Clinical Infectious Diseases and Antimicrobial Resistance. Get access to this online course when you register for our in-person course, Transplant and Oncology Infectious Diseases. Learn more about the life and legacy of Dr. Pamela Tucker. This two-day, in-person
Source: www.hopkinsmedicine.orgCategories: General Medicine News, Infectious DiseaseTweet-
RT @ShohamTxID: https://t.co/fU185EbXpB We are excited about this course. We are sure @Contagion_Live readers will find this course worthw…
-
-
Mashup Score: 2Bacteria Bioengineered to Express Healing Chemokine Demonstrates Promise for MDR Wound Infections - 5 day(s) ago
Bacteria genetically engineered to express human chemokine to enhance wound healing demonstrates direct activity against MDR bacteria in-vitro.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
Bacteria genetically engineered to express human chemokine to enhance wound healing demonstrates direct activity against MDR bacteria in-vitro. Principal investigator Mia Phillipson discusses her research. #IDtwitter #MedTwitter https://t.co/KrwFSZKvy1
-
-
Mashup Score: 8Rethinking Fungal Blood Cultures in Sepsis Workups - 6 day(s) ago
Logan Brock, PharmD, presents data at MAD-ID 2025, showing limited diagnostic yield from routine fungal cultures and delayed results compared to standard methods.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
At #MADID2025, Dr. Logan Brock presented that routine fungal blood cultures during sepsis evaluations may offer limited diagnostic value; a more targeted approach may be appropriate. @MAD_ID_ASP Listen here: https://t.co/dk343V0VZ7
-
-
Mashup Score: 8MAD-ID - 6 day(s) ago
Contagion® is a news resource for infectious disease specialists and practitioners, aiding identification, diagnosis, treatment and prevention.
Source: www.contagionlive.comCategories: General Medicine News, Infectious DiseaseTweet-
We’ve touched down in Orlando for #MADID2025! 🌴 We’re looking forward to our 15+ on-site interviews w/ leading clinicians & sharing their important work in ID & AMR with our audience. @MAD_ID_ASP You can find our coverage here: https://t.co/GUVFIpDpK9 https://t.co/AfyUbbuR3Z
-
At #MADID2025, Dr's. Julia F. & Christina Lee from @UNCMedCenter presented that immunocompromised patients on OPAT had a 27.1% 30-day readmission rate compared to 14.1% in non-immunocompromised patients. @MAD_ID_ASP Listen here: https://t.co/y9LmrfKg4h